ITRM
Iterum Therapeutics PLC
NASDAQ: ITRM · HEALTHCARE · BIOTECHNOLOGY
$0.03
+0.00% today
Updated 2026-04-29
Market cap
$3.75M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $1
Volume
32.7M
Iterum Therapeutics PLC (ITRM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,982.00%
ROE
-556.00%
ROA
-53.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-13.46M | — | — | — |
| 2017 | $508000.00 | $-29.41M | 100.00% | -5,798.23% | -5,788.58% |
| 2018 | $869000.00 | $-77.06M | 100.00% | -8,810.01% | -8,867.20% |
| 2019 | $37000.00 | $-103.13M | 100.00% | -275,732.43% | -278,729.73% |
| 2020 | $0.00 | $-52.01M | — | — | — |
| 2021 | $0.00 | $-91.56M | — | — | — |
| 2022 | $0.00 | $-44.43M | — | — | — |
| 2023 | $0.00 | $-38.37M | — | — | — |
| 2024 | $0.00 | $-24.77M | — | — | — |